Stocktoria

Savara Inc SVRA

Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2001-06-25 · LEI

Savara Inc statistics & valuation

P / B6.0×
Net cash$3.3M
Enterprise value USD$1.2B
Earnings yield EBIT/EV-10.2%
Return on capital-53%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Gross margin (%)
2016201720182019202020212022202320242025
Operating margin (%)
-2737.00% -19182.90% 2016201720182019202020212022202320242025
Return on equity (%)
-25.00% -56.80% -76.90% -77.10% -29.80% -35.40% -39.00% -55.90% -58.50% 2016201720182019202020212022202320242025
Shares outstanding
3.2M 30.5M 35.1M 50.8M 54.2M 133.9M 152.8M 165.2M 198.2M 222.4M 2016201720182019202020212022202320242025
Net debt ($)
$2.2M -$8.4M -$26.0M -$237000 $11.5M -$3.3M 2016201720182019202020212022202320242025
Share buybacks ($)
2016201720182019202020212022202320242025
Return on assets (%)
-37.80% -18.70% -40.40% -57.40% -50.80% -24.40% -27.30% -30.80% -45.00% -46.90% 2016201720182019202020212022202320242025
Free cash flow margin (%)
-2094.50% -15518.70% 2016201720182019202020212022202320242025
Debt / equity (×)
0.39× 0.18× 0.24× 0.19× 0.16× 0.15× 2016201720182019202020212022202320242025
EPS ($)
-$0.32 -$0.25 -$0.33 -$0.48 -$0.53 2016201720182019202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Operating margin-19182.9%-2737.0%
Net margin-19305.4%-2730.8%
FCF margin-15518.7%-2094.5%
Return on assets-46.9%-45.0%-30.8%-27.3%-24.4%-50.8%-57.4%-40.4%-18.7%-37.8%
Return on equity-58.5%-55.9%-39.0%-35.4%-29.8%-77.1%-76.9%-56.8%-25.0%30.4%
Debt / equity0.15×0.16×0.19×0.24×0.18×0.39×
Current ratio11.8513.7315.6621.9811.2610.4111.4015.6316.274.23

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.